No, research shows no significant effect specifically on belly fat or waist circumference
well-tolerated in mice, rats, rabbits, and dogs with no serious organ toxicity.[34][35] Clinical Safety : Mild local irritation possible at injection sites, but no systemic adverse effects reported in trials.[36][37] Potential Risks : Theoretical concerns include pro-angiogenic effects potentially promoting tumor growth, though no evidence supports this in studies.[38] Long-term human data is limited, so monitoring is advised
Allosteric regulation has long been recognized for other NRs [77, 81] and has become more apparent and accepted as a mode of regulation for AR activity over the past decade, based on literature reports as those described above
It does not represent evidence of safety, efficacy, or suitability for administration in vivo use beyond controlled research settings
Many Canadians find themselves searching for ways to support their internal resilience as they age or navigate the demands of a busy lifestyle
For that to happen, BPC-157 would first need to go through the entire FDA approval process for human therapeutic use, which would take many years of successful clinical trials
